EP
TMCI icon

Essential Partners’s Treace Medical Concepts TMCI Stock Holding History

Essential Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7K Buy
929
+718
+340% +$1.97K ﹤0.01% 1680
2026
Q1 		$283 Buy
+211
New +$421 ﹤0.01% 2559
2025
Q4 		– Sell
-937
Closed -$6.29K – 2913
2025
Q3 		$6.29K Buy
937
+654
+231% +$4.27K ﹤0.01% 1342
2025
Q2 		$1.66K Buy
+283
New +$1.84K ﹤0.01% 1368

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Essential Partners's TMCI Position: Q2 2026 in Review

Essential Partners increased its Treace Medical Concepts (TMCI) stake by 340% in Q2 2026, buying an estimated $1.97K and bringing the position to 929 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Essential Partners first reported a position in TMCI in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.29K in Q3 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Essential Partners held 929 shares of Treace Medical Concepts worth $3.7K as of Q2 2026.
  • Essential Partners bought 718 Treace Medical Concepts shares in Q2 2026, an estimated $1.97K.
  • Treace Medical Concepts made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1680 holding.
  • Essential Partners first reported a position in Treace Medical Concepts in Q2 2025 and has held it in 4 quarters since.
  • Essential Partners's Treace Medical Concepts position peaked at $6.29K in Q3 2025.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.